These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23922313)

  • 1. Robust inference from multiple test statistics via permutations: a better alternative to the single test statistic approach for randomized trials.
    Ganju J; Yu X; Ma GJ
    Pharm Stat; 2013; 12(5):282-90. PubMed ID: 23922313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust inference for group sequential trials.
    Ganju J; Lin Y; Zhou K
    Pharm Stat; 2017 Mar; 16(2):167-173. PubMed ID: 28133895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for increased power from combining P-values testing the same hypothesis.
    Ganju J; Julie Ma G
    Stat Methods Med Res; 2017 Feb; 26(1):64-74. PubMed ID: 24919832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening the understanding of the relationship between survival designs and test statistics.
    Ma G; Ganju J
    Pharm Stat; 2010; 9(2):113-24. PubMed ID: 19507135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.
    Proschan M; Follmann D
    Stat Med; 2008 Mar; 27(6):795-809. PubMed ID: 17594680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient statistical inference for a parallel study with missing data by using an exact method.
    Shan G; Hutson A; Wilding GE; Ma C; Tian GL
    J Biopharm Stat; 2019; 29(3):478-490. PubMed ID: 31017028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric methods for microarray data based on exchangeability and borrowed power.
    Lee ML; Whitmore GA; Björkbacka H; Freeman MW
    J Biopharm Stat; 2005; 15(5):783-97. PubMed ID: 16078385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to use likelihood ratios to interpret evidence from randomized trials.
    Perneger TV
    J Clin Epidemiol; 2021 Aug; 136():235-242. PubMed ID: 33930527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantile-function based null distribution in resampling based multiple testing.
    van der Laan MJ; Hubbard AE
    Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of null statistics in permutation-based multiple testing for multi-factorial microarray experiments.
    Gao X
    Bioinformatics; 2006 Jun; 22(12):1486-94. PubMed ID: 16574697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bootstrap and second-order tests of risk difference.
    Lloyd CJ
    Biometrics; 2010 Sep; 66(3):975-82. PubMed ID: 19912176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2004 Jun; 43(11):1929-39. PubMed ID: 15172393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous use of weighted logrank and standardized Kaplan-Meier statistics.
    Yang P; Fleming TR
    J Biopharm Stat; 2006; 16(2):241-52. PubMed ID: 16584070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy evaluation for monotherapies in two-by-two factorial trials.
    Hung HM; Chi GY; O'Neill RT
    Biometrics; 1995 Dec; 51(4):1483-93. PubMed ID: 8589235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single test for rejecting the null hypothesis in subgroups and in the overall sample.
    Lin Y; Zhou K; Ganju J
    J Biopharm Stat; 2017; 27(1):101-110. PubMed ID: 26891426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage group sequential robust tests in family-based association studies: controlling type I error.
    Yan LK; Zheng G; Li Z
    Ann Hum Genet; 2008 Jul; 72(Pt 4):557-65. PubMed ID: 18325081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.